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Priming of transcriptional memory 
responses via the chromatin 
accessibility landscape in T cells
Wen Juan Tu1,*, Kristine Hardy1,*, Christopher R. Sutton1, Robert McCuaig1, Jasmine Li2,3, 
Jenny Dunn1, Abel Tan1, Vedran Brezar4, Melanie Morris1, Gareth Denyer5, Sau Kuen Lee6,7, 
Stephen J. Turner2,3, Nabila Seddiki4, Corey Smith6,7, Rajiv Khanna6,7 & Sudha Rao1
Memory T cells exhibit transcriptional memory and “remember” their previous pathogenic encounter to 
increase transcription on re-infection. However, how this transcriptional priming response is regulated 
is unknown. Here we performed global FAIRE-seq profiling of chromatin accessibility in a human 
T cell transcriptional memory model. Primary activation induced persistent accessibility changes, 
and secondary activation induced secondary-specific opening of previously less accessible regions 
associated with enhanced expression of memory-responsive genes. Increased accessibility occurred 
largely in distal regulatory regions and was associated with increased histone acetylation and relative 
H3.3 deposition. The enhanced re-stimulation response was linked to the strength of initial PKC-
induced signalling, and PKC-sensitive increases in accessibility upon initial stimulation showed higher 
accessibility on re-stimulation. While accessibility maintenance was associated with ETS-1, accessibility 
at re-stimulation-specific regions was linked to NFAT, especially in combination with ETS-1, EGR, 
GATA, NFκB, and NR4A. Furthermore, NFATC1 was directly regulated by ETS-1 at an enhancer region. 
In contrast to the factors that increased accessibility, signalling from bHLH and ZEB family members 
enhanced decreased accessibility upon re-stimulation. Interplay between distal regulatory elements, 
accessibility, and the combined action of sequence-specific transcription factors allows transcriptional 
memory-responsive genes to “remember” their initial environmental encounter.
Naïve T cells exist at rest until exposed to activating signals from antigen presenting cells. This activates transcrip-
tion to co-ordinate proliferation, differentiation, and the production of inflammatory molecules to clear infection. 
Naïve and memory T cell transcriptomes are similar apart from a distinct subset of genes involved in processes 
such as cell adhesion and survival1,2. In contrast to naïve T cells, memory T cells are primed for a rapid response to 
antigenic re-exposure1–3. This enhanced response is in part attributed to more efficient T cell receptor (TCR) sig-
nalling such as increased activity of ZAP-704, the MAP kinases5,6, and protein kinase C (PKC)7. PKC family mem-
bers -θ , η , α , δ are important in T lymphocyte signalling8,9. T cell activation with phorbol 12-myristate 13-acetate 
(PMA) can activate the “novel” PKCs (including PKC-θ ) and, when administered with calcium ionophore, the 
conventional PKCs10. Together, PMA and calcium ionophore mimic T lymphocyte activation and induce genes 
such as IL2 and TNF11,12. PKC-θ signalling activates a number of transcription factors including the NFκ B family 
members as well as AP1 and NFAT8,13,14, which have a major role in regulating chromatin configuration upon T 
cell activation15,16.
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Chromatin modifications are different at regulatory regions of memory-responsive genes poised for rapid 
expression3,17,18. DNA winding around histones affects accessibility to RNA polymerase II (Pol II) and other 
regulators to control transcription. Histone modifications19 and the incorporation of histone variants20,21 regu-
late histone-DNA interactions to control chromatin accessibility. Histone modifications such as H3K4me3 and 
H3K9ac identify “active” transcriptional start sites (TSSs) and gene promoters, while others such as H3K4me1 
and H3K27ac identify distal regulatory elements (enhancers)22. Formaldehyde-assisted isolation of regulatory 
elements (FAIRE) is one technique that can measure chromatin accessibility. Combined with high-throughput 
sequencing (FAIRE-seq), it has been used to demonstrate that chromatin accessibility changes during cellular dif-
ferentiation in adipocytes23, myeloid cells24, and breast epithelial cells25 largely occur at promoters and enhancers.
To understand the process of T cell response priming, we globally profiled chromatin accessibility by 
FAIRE-seq in a previously described7 human T cell (Jurkat) transcriptional memory (JTM) model of four dis-
tinct transcriptional states: 1) non-stimulated cells, 2) stimulated cells, 3) “transcriptionally experienced” or 
memory-like cells after stimulus withdrawal, and 4) re-stimulated memory-like cells. We found that the initial 
stimulation alters the chromatin accessibility landscape, especially at regions distant from TSSs. Many of these 
alterations persisted in the resting memory state, and secondary activation induced secondary-specific opening 
of previously restricted regions. We identified and characterised regions with enhanced chromatin accessibility 
that associated with increased expression of memory-responsive genes and identified a role for the combinatory 
action of transcription factors, unravelling a central role for NFAT and ETS in regulating these regions. Lastly, we 
perturbed the initial PKC signal and subsequent NFAT and NFκ B activation to help dissect the pathways involved 
in regulating the changes in chromatin accessibility in transcriptional memory. Overall, transcriptional responses 
are primed via the chromatin accessibility landscape in memory T cells.
Results
Primary stimulation irreversibly alters the chromatin accessibility landscape. We performed 
genome-wide FAIRE-seq analysis of open chromatin in the Jurkat transcription memory (JTM) model to deter-
mine the chromatin accessibility domains marking transcriptional memory-responsive genes. The JTM model7 
consists of four cell states: NS (non-stimulated naïve T cells), ST (PMA and ionomycin (I) stimulated), SW (stim-
ulus withdrawal, memory-like T cells), and RS cells (re-stimulation of the memory-like T cell state) (Fig. 1a). The 
cells were pre-treated with DMSO as a vehicle control for the experiments with the PKC inhibitor rottlerin. The 
stimulation of Jurkat cells globally altered chromatin accessibility (Spearman’s rank correlation 0.78 compared to 
NS; Fig. 1b), and this overall difference partly persisted in SW (ρ = 0.80). However, the greatest chromatin acces-
sibility changes were detected in RS (ρ = 0.70). For comparison, rottlerin pre-treatment of NS cells, which was not 
expected to induce changes, had ρ = 0.93 compared to the DMSO pre-treated NS cells.
We next identified regions with increased or decreased chromatin accessibility in ST, SW, and RS cells com-
pared to NS cells (see Methods, Fig. S1A–D) and their overlap (Fig. 1c,d). The 5337 regions with increased chro-
matin accessibility in ST, SW, and/or RS cells were classified into sets (sets a–g, Fig. 1c,e). Regions in sets b and 
e showing greater chromatin accessibility in ST and RS cells were further subdivided depending on whether 
accessibility was greater in ST (b1,e1) or RS (b2,e2). This included patterns with: chromatin accessibility greatest 
in primary (1°) activation (1° enriched; a, b1,e1); chromatin accessibility greatest in secondary (2°) activation 
(2° enriched; b2,c,e2); and high chromatin accessibility in SW (f,g). Of the 2516 regions with increased chromatin 
accessibility in ST (a,b,d,e), 671 retained CA in SW (d,e; Fig. 1c) and 579 regions (e) were common to the ST, SW, 
and RS samples. A further 1391 regions (f,g) had “delayed” greater chromatin accessibility in SW compared to NS 
controls, with 492 of these also having chromatin accessibility in RS cells (f, Fig. 1c). In RS, 1013 regions (b) with 
reversed chromatin accessibility in SW were re-induced, and accessibility increases at 1430 2° specific regions 
(c) were identified. Regions with decreased chromatin accessibility relative to NS were similarly grouped (h–n) 
(Fig. 1d). Decreases tended to be less reversible than increases in accessibility. Overall, RS had the greatest num-
ber of regions with increased or decreased chromatin accessibility and had more increased regions in common 
with ST than with SW cells.
Here, FAIRE-seq identified four patterns with enhanced chromatin accessibility in RS: (i) 
stimulation-dependent chromatin accessibility that is lost in SW but enhanced upon RS (b2); (ii) 2°-specific 
chromatin accessibility detected only in the RS state (c); (iii) persistent chromatin accessibility that remains in 
cells from ST and SW but is highest in RS (e2); and (iv) delayed chromatin accessibility that is detected in SW and 
RS T cells (f).
Altered chromatin accessibility regions occur near immune pathway genes, with increased 
chromatin accessibility in RS occurring near memory-responsive genes. We identified the nearest 
genes to the regions and found that in comparison to regions that exhibited little change in chromatin acces-
sibility, those with differential accessibility were primarily located in intron and intergenic regions (Fig. S1F). 
Genes near increased chromatin accessibility regions were significantly enriched for TCR and chemokine sig-
nalling pathways (Fig. 1f, Fig. S1G). Genes associated with regions that exhibited either increased or decreased 
accessibility were enriched for immune-related terms including lymphocyte activation, haematopoietic devel-
opment, regulation of apoptosis, cell morphogenesis, and cell adhesion processes (Fig. 1f). Of note, a subset of 
immune-responsive genes including CXCR5, PLCG2, DOCK2, CSF1, and BCL3 were associated with increased 
chromatin accessibility regions in SW cells, and while their transcription did not necessarily change in Jurkat 
cells, increased transcription was observed in in vivo models of T cell memory and/or differentiation (Fig. 1g). 
This supports a role for the primary TCR signal in changing the plasticity of the chromatin accessibility landscape 
so that cues such as cytokines can activate signalling pathways whose target transcription factors can then access 
these opened regulatory regions and activate transcription.
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Figure 1. Initial T cell stimulation alters the immune gene DNA accessibility landscape with enduring 
consequences upon stimulus removal. (a) Schematic of the Jurkat transcriptional memory model. Non-
stimulated (NS) Jurkat T cells were stimulated with PMA and ionomycin (ST), washed, and rested (SW) before 
re-stimulation (RS). (b) FAIRE-seq Spearman correlation. (c,d) Region with more (c) or less (d) accessibility in 
ST, SW, and RS cells compared to NS cells. Sets with altered accessibility in RS and ST were divided according 
to whether the accessibility was higher (≥ 1.75) in ST (1) or RS (2). (e) Mean Z-score profiles of the increased 
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We next used JTM microarray data (GSE61172; same as FAIRE-seq except with 9 day SW) to determine 
the relationship between chromatin accessibility changes and transcription of memory-responsive genes. As 
regulatory regions can act on genes up to 750 kb away25, we examined the relationship between regions and 
expression by determining the percentage of memory-responsive genes (expression higher in RS than NS 
and ST) or “1° response” genes (higher expression in ST than NS and RS) which had TSSs within 50 kb of the 
region sets (Fig. 1h). Regions exhibiting increased chromatin accessibility in 1° (a,b1,e1) and 2° states (b2,c,e2) 
demonstrated a greater association with 1° response genes than expected (p < 0.05). There were significantly 
more memory-responsive genes within 50 kb of all 2° enriched sets, SW enriched sets (f and g), and set b1 than 
expected (p < 3 × 10−6). Genes exhibiting decreased transcription in RS cells (Fig. S1H) were generally associated 
with regions that exhibited a decrease in chromatin accessibility.
Memory-responsive genes with 2°-specific memory chromatin accessibility regions (c) included IL8, ID2, and 
FASLG. Memory-responsive genes with persistent (e2) or delayed memory (f) chromatin accessibility included 
MIR21, BIRC3, PRDM8, TNFSF10, DUSP10, MIR155, and LTA (Fig. S2A). The region near LTA can enhance 
LTA and TNF transcription in reporter plasmids26,27, and, in stimulated T cells, contacts the TNF promoter27; we 
refer to this region as LTA/TNF. Interestingly, many memory-responsive genes near these SW accessible regions 
had low transcription in SW cells (Fig. S2), suggesting that this chromatin accessibility may prime genes for an 
enhanced response upon RS rather than contribute to transcription in SW.
Contacts between distal regulatory regions and their promoter targets have been reported to strengthen upon 
stimulation27, while others have suggested that contact reflects a preconfigured state for transcriptional pois-
ing28–30. Chromosome conformation capture (3C) can be used to determine if distal elements are in close contact 
to the TSSs of particular genes31. Using primers targeting three of our memory accessible regions located 6–35 kb 
from the TSSs of the memory-responsive genes DUSP10, BCL6, and TNFSF10 (Fig. S3), we compared distal TSS 
interactions of these memory-responsive genes in NS, ST, and SW (6 days) cells. We also used control primers for 
a gene desert region32 to measure background interactions occurring by chance. Interactions were significantly 
greater in NS and ST cells for TNFSF10 (p = 0.025 and 0.011) than the 8.7 kb control, and a similar interaction was 
also detected for BCL6 (p = 0.021 and 0.002) and DUSP10 (p = 0.001 and 0.043) compared to the 25 kb control 
(Fig. 1i). There was no amplification of the 34 kb control region in any treatment. Unexpectedly, interactions were 
not significant in SW cells, although still stronger on average than control regions. When normalised for control 
region interactions, changes across treatments were not significant and the differences in control region interac-
tions across treatments indicate that they are incomparable. Thus, at least for the regions examined, the memory 
accessible enhancer regions interacted with promoters of memory-responsive genes, and these interactions were 
present in NS cells before increased gene expression upon activation.
Changes in chromatin accessibility primarily occur in enhancer regions and occur in CD4+ mem-
ory lymphocytes in selected human individuals. As a large proportion of the changes in chromatin 
accessibility occurred away from a TSS, we examined if they were occurring in genomic regions containing his-
tone marks associated with regulatory elements such as enhancers. We used Roadmap chromatin state annota-
tions22 to profile the histone environment of our regions in different primary cell types including CD4+ naïve 
and memory cells. We initially grouped the chromatin states into permissive (H3K4me3), enhancer (H3K4me1/
H3K27ac), transcription (H3K36me3), repressive (H3K27me3), heterochromatin (H3K9me3), and quiescent 
(low or no marks). While 33% of regions with unchanged chromatin accessibility were in permissive regions 
in CD4+ memory cells, less than 21% of any of the sets with increased chromatin accessibility were associated 
with such permissive regions (Fig. 2a). Instead, larger proportions of sets that exhibited an increase in chromatin 
accessibility overlapped with enhancer regions (35–50%, Fig. 2a). In contrast to the less cell-specific permissive 
regions, the majority of enhancer regions with increased chromatin accessibility were more cell specific and only 
had enhancer chromatin marks in T cells or CD34+ progenitor cells (Fig. S4A).
Using the H3K27ac, H3K4me3, and H3K4me1 marks in naïve, memory, and PMA/I-stimulated Th cells from 
the same donor22, we examined the FAIRE peak positions with respect to the modified histones using aver-
age ChIP-seq data profiles (Fig. 2b). The modified histones flanked accessible regions, particularly in activated 
cells. These profile shape changes suggested that chromatin accessibility increases could be associated with 
flanking nucleosomes becoming more fixed in their positions and the development of a “nucleosome-depleted 
region” (Fig. 2b). This could at least in part be due to increases in histone marks such as acetylation and/or H3K4 
methylation.
accessibility sets. (f) Over-represented Gene Ontology biological pathways and KEGG pathways in the genes 
nearest to the regions with increased or decreased accessibility. (g) The expression of genes near SW > NS 
accessible regions that are upregulated in effector memory (EM), activated memory (AM), naïve Tregs (NT), 
and memory Tregs (MT) compared to naïve (N) (from E-MEXP-2578). Immune response genes are labelled. 
Heat map Z-score scaled. (h) The percentage of primary response genes (PRG), all genes on the array, and 
memory-responsive genes (MRG) with transcriptional start sites (TSSs) within 50 kb of a region for the different 
subsets. *p < 0.05, **p < 0.001, ***p < 1 × 10−5, compared to all genes on array, Fisher’s exact test.(i) Chromatin 
conformation capture ligation efficiencies indicating interactions between TNFSF10, DUSP10, and BCL6 
enhancers and gene TSSs. The contact frequencies of the gene desert region with similar distances were used 
as a control. 3C-qPCR data were normalised to bacterial artificial chromosome (BAC) clone ligation products 
(mean ± SEM, n = 4–5 biological replicates, *p < 0.05, t-test). Interaction frequency should be considered 
within a treatment relative to the gene desert region and not across treatments.
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Based on relative H3K27ac and H3K4me1 levels, Roadmap divides enhancer states into weak, active and 
poised. Most accessible regions annotated as enhancers were in a weak state in naïve cells (Fig. 2c). However, in 
the delayed (f) and persistent memory (e2) sets, 20–22% of the weak enhancers gained H3K27ac in memory cells 
to become active enhancers. Furthermore, 21–22% of quiescent regions in these sets gained enhancer marks. In 
contrast, a greater proportion of the weak enhancers in sets with corresponding decreases in chromatin accessi-
bility (m and l2) lost H3K4me1 (18–21%) (Fig. S4B). With respect to the four different memory chromatin acces-
sibility groups (b2,c,e2,f), 34–46% of regions which were weak enhancers in naïve cells became active enhancers 
Figure 2. Changes in the chromatin accessibility (CA) landscape occur in regions with enhancer or 
permissive chromatin environments in primary CD4 lymphocytes. (a) Regions in the sets with increased 
chromatin accessibility were annotated by their chromatin state segmentation in CD4+ memory cells. The 
chromatin state data were summarised from CD4+ Roadmap data: quiescent (quies, low level of marks), 
repressive (repr, H3K27me3), transcription (trans, H3K36me3), enhancer (enh, H3K4me1), permissive (perm, 
H3K4me3), and heterochromatin (het, H3K9me3). (b) H3K4me3, H3K27ac, and H3K4me1levels around 
the FAIRE peaks in the transcriptional memory sets in naïve (faint line), memory (dark line), and PMA/I 
stimulated Th (dotted line) lymphocytes. Average profiles are of sequencing tags per 100 bp. (c) Detailed 
chromatin state of the memory regions in naïve (N), memory (M), and PMA/I stimulated Th (S) CD4+ 
lymphocytes. Those regions within 50 kb of an MRG TSS are marked with a black line. Transcribed (Tx), 
Permissive (Tss), Enhancer (Enh). (d,e) Fold change in FAIRE chromatin accessibility of CD4+ memory cells 
compared to naïve cells (Log2). Naïve (CD4+ CD45RA+ CCR7+ CD27+) and memory (CD4+ CD45RA− blood 
lymphocytes were isolated from 6 donors (biological replicates). Chromatin accessibility was measured by 
qPCR and normalised to the PPIA promoter. Boxplots show median and first to fourth quartiles (*p < 0.05, 
**p < 0.01, one sample t-test against 0).
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in PMA/I-stimulated Th cells, and 17–26% of the quiescent regions had enhancer marks (Fig. 2c). Regions near 
memory-responsive genes were mainly located in permissive or enhancer environments (Fig. 2c).
To determine if primary memory T cells also showed increased chromatin accessibility at regions with delayed 
or persistent memory in the JTM, we performed FAIRE-PCR on naïve and memory CD4+ cells isolated from six 
healthy donors (Fig. 2d,e). Nine candidate regions near memory-responsive genes were chosen that had either 
delayed memory (TNFSF10, MIR155, DUSP10), persistent memory (PRDM8, BCL12A1, LTA/TNF, BIRC3, 
MIR21), or otherwise maintained chromatin accessibility in SW cells (BCL6). Regions close to DUSP10, BCL6, 
MIR155, BIRC3, and LTA/TNF had significantly higher chromatin accessibility levels in memory CD4+ cells com-
pared to naïve cells (Fig. 2e). Interestingly, not all donors had increased accessibility for all regions, and different 
donors did not have increased accessibility detected for different regions, most noticeably donor 4 and MIR21. It 
would be interesting to determine whether this variability reflects differences in memory subsets and if individual 
memory lymphocytes show variability within the same donor.
Together, the Roadmap analysis and primary cell experiments highlight the overlap between changes in pri-
mary cells and the JTM and that changes in chromatin accessibility occur in regions with enhancer or weak 
permissive chromatin marks.
Stimulation-induced changes in chromatin accessibility are related to changes in H3 and H2AZ 
levels and acetylation and persist throughout cell division despite stimulus withdrawal. In 
agreement with other studies33,34, the chromatin state transitions suggest that histone modifications might medi-
ate a subset of chromatin accessibility changes. Histone variants also influence chromatin accessibility21, and we 
have previously observed variant exchange at inducible gene promoters upon stimulation35. We used the pro-
moter of BIRC3 (e2) and the enhancer of TNFSF10 (f) as illustrative examples to examine the deposition of H2A. 
Z and H3.3 variants and the enrichment of tail (H3K27) and globular (H3K56) acetylation (Fig. 3a). H2A. Z but 
not H3 levels significantly decreased on stimulation (Fig. 3a). In SW, despite significantly lower levels of H2AZ 
being detected at the TNFSF10 enhancer region compared to NS, a greater proportion of the H2AZ was acetylated 
(Fig. 3a). Similar to H2AZ, H3 levels were significantly decreased at both of these regions in SW, but K27 and K56 
were highly acetylated and this profile was accompanied by increases in H3.3 deposition (Fig. 3a). There was no 
increase in the H3K4me1 enhancer mark at the TNFSF10 region, although there was evidence of relatively higher 
H3K4me3 in SW cells for the BIRC3 promoter (Fig. S4C). In RS, H2AZ levels decreased further.
We have previously shown that SW Jurkat cells maintain the ability to induce enhanced IL2 transcription 
after several cell divisions7. To establish whether increased chromatin accessibility persists through cell division, 
FAIRE-PCR was performed on SW and RS cells rested for 6 days after stimulation. Jurkat cells stimulated with 
Figure 3. Changes in chromatin accessibility (CA) are associated with altered histone acetylation and 
variant occupancy and can be remembered through cell division. (a) ChIP-qPCR analysis of H2A.Z, H2A. 
Zac, H3, H3.3, H3K27ac, and H3K56ac binding at the BIRC3 promoter and TNFSF10 enhancer in the Jurkat 
model. ChIP enrichment ratio relative to NS is shown (mean ± SEM, n = 3 biological replicates). *p < 0.05, 
**p < 0.01, t-test. (b) FAIRE chromatin accessibility in the Jurkat model with 6 day resting time. Fold change 
compared to NS. Chromatin accessibility was normalised to the GAPDH promoter (mean ± SEM, n = 3 
biological replicates, black * compared to NS, red * ST compared to RS, t-test, *p < 0.05, **p < 0.01, ***p < 0.001, 
****p < 0.0001).
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Figure 4. The transcription factor motifs that characterise the different sets of increased chromatin 
accessibility (CA). (a) The top overrepresented motifs in the sets with increased chromatin accessibility. Results 
from HOMER, *p < 0.05, ***p < 1 × 10−5, Benjamini q value, compared to control sets with similar GC content 
(trend line). (b) The top overrepresented JASPAR motif families in the sets. Enrichment scores > 50 (scores 
shown in brackets) and CLOVER significance p value < 0.05 relative to NS regions. (c) The relative proportions 
of the region sets with increased or decreased chromatin accessibility. (d–i) The numbers of regions with various 
JASPAR transcription factor binding motif combinations and their chromatin accessibility sets. Regions of 
increased chromatin accessibility occur first (clockwise).
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PMA/I and then washed underwent cell division at least 6 times over the following 6 days (Fig. S2D). In addition 
to the 9 aforementioned candidate regions, we also examined: 3 with 2°-specific memory near memory-responsive 
genes (IL8, FASL, ID2); 3 (CREB5, DUSP2, and BACH2) with similar chromatin accessibility in ST and RS that 
were near inducible genes with similar transcription, and 1 (TRIB3) that had higher chromatin accessibility and 
transcription in ST cells. After 6 days of rest, the response to re-stimulation was significantly higher than that for 
1° stimulation for regions from the different memory chromatin accessibility groups except for PRDM8 and IL8, 
which showed non-significant increases (Fig. 3b). The delayed and persistent memory regions near TNFSF10, 
MIR155, DUSP10, BCL2A1, LTA/TNF, BIRC3, and MIR21 all maintained significant increases in SW day 6 sam-
ples (p < 0.05), with BCL6 and PRDM8 showing consistent but non-significant increases (Fig. 3b). In contrast, 
the 4 control regions and 2 2°-specific regions (IL8 and FASLG) had similar chromatin accessibility levels in the 
NS and day 6 SW samples (Fig. 3b). Increased chromatin accessibility is, therefore, at least partially maintained 
throughout at least 6 cell divisions, and the increased chromatin accessibility changes likely reflect decreases in 
nucleosome occupancy with exchange of H3.3 and relative increases in acetylation of the histones.
NFAT binding sites are associated with chromatin accessibility in RS cells, and ETS and GATA 
sites are associated with maintenance of chromatin accessibility. To identify the transcription 
factors responsible for changes in chromatin accessibility, we examined the regions for over-represented tran-
scription factor binding motifs (Fig. 4a,b, Fig. S5B). AP1, EGR, RUNX, ETS, NFκ B, NFAT, nuclear receptors, 
TCF7L2 (HMG), and GATA DNA-binding motif families were significantly enriched in regions with increased 
chromatin accessibility, but their enrichment altered over the region sets (Fig. 4a,b). AP1, EGR, NFκ B, and NFAT 
were most enriched in sets with increases in ST and/or RS cells, with AP1 enriched more in the 1° sets (a,b1,d, and 
e1) with higher chromatin accessibility in ST cells and NFAT more in sets b2 and c with higher chromatin acces-
sibility in RS cells (Fig. 4a,b). Examination of expression of the factors that bind these motifs indicated that many 
were inducible (Fig. S5A). Differential induction of several of the factors that bind the AP1 motif, including ATF3 
and FOS, in ST and RS cells may contribute to differences in the chromatin accessibility patterns of the various 
AP1-containing regions. Interestingly, the ETS motif was more enriched in sets c-g, particularly those that main-
tain chromatin accessibility in SW cells (Fig. 4). Similarly, the GATA motif was most enriched in sets e2, f, and g.
By comparison, bHLH family motifs were enriched in decreased chromatin accessibility regions (Fig. S5B,C). 
Unlike other families, there were differences between different members. While at least 3 of the factors that bound 
to this motif family - TCF3, TCF12, and TFAP4 - decreased expression with stimulation, the altered chromatin 
accessibility may also have been due to increased expression of the inhibitory ID family, which also bind the motif 
(Fig. S5A).
Many motif combinations increased the relative percentage of regions in a given set. Set c comprised 16% of 
all regions in sets a-n (Fig. 4c), a percentage that increased in regions containing both NFAT and GATA or EGR 
and GATA (Fig. S5) and even further in regions containing all 3 motifs (Fig. 4d). The proportion of set c regions 
also increased in those containing NFAT and ETS but not bHLH (CACC) (Fig. 4e). Strikingly, when we examined 
every combination of regions that contained one of the motifs of interest but lacked the NFAT motif, there was a 
marked decrease in the percentage of regions accessible more in RS (b2, c) (Fig. S6). The co-occurrence of NFAT 
and NFκ B not only favoured increased chromatin accessibility in 2° regions (Fig. 4f,g), but also had the highest 
proportion of regions near a memory-responsive gene, and 11% of regions with NFAT, NFκ B, and NR4A were 
near a memory-responsive gene.
For AP1-containing regions, co-occurrence with NFAT and/or NFκ B increased the proportion of regions in b2 
(Fig. 4f), while co-occurrence with ZEB and/or EGR increased set b1 and a proportions (Fig. 4h). Co-occurrence 
of ZEB appeared to influence bHLH-containing regions, resulting in more set l2 (Fig. 4i).
In summary, different transcription factor family combinations decorate regions accessible in ST, SW and RS. 
AP1 and bHLH have dominant roles in respectively regulating increased and decreased chromatin accessibility 
upon ST, while ETS and GATA are associated with chromatin accessibility in SW and NFAT is strongly linked to 
enhanced chromatin accessibility upon RS.
The enhanced memory response of several genes is ETS-1 dependent. As motif analysis suggested 
a role for ETS family members in maintaining chromatin accessibility (Fig. 4) and ETS1 was highly expressed 
(Fig. S5A), we examined the role of ETS-1 in chromatin accessibility and gene expression. ETS-1 protein was 
expressed in NS and ST human primary CD4+ naïve and memory cells (Fig. 5a), and ETS-1 ChIP-seq of CD4+ 
cells (GSE4311936) showed that ETS-1 binds to about half of SW > NS regions (Fig. 5b). ETS-1 protein was pres-
ent in NS cells and remained stable in ST (Fig. 5c). However, ETS-1 binding at the BIRC3 promoter and TNFSF10 
enhancer region was highest in SW (Fig. 5d).
To assess the contribution of ETS-1 to the memory response, ETS1 was knocked down (Fig. 5e). The enhanced 
expression of BIRC3, MIR21, TNFSF10, TNF, and PRDM8 in RS cells was consistently reduced in the presence of 
ETS1 siRNA (Fig. 5f), with decreased expression of TNFSF10 and PRDM8 in SW cells. The effects of ETS1 knock-
down on chromatin accessibility were subtler, but consistent chromatin accessibility decreases were observed on 
RS at the BIRC3, TNF and MIR21 promoter regions and the DUSP10 enhancer (Fig. 5g). Thus, ETS-1 may bind 
at regions accessible in SW and play a role in enhancing the recruitment of stimulation-induced factors to these 
regions upon RS.
Abrogation of initiating stimuli by rottlerin inhibits aspects of the enhanced 2° response. PMA 
activates several PKC isoforms including PKC-θ , which plays a central role in T cell activation8. Treatment with 
PMA/I induces transcription of genes such as IL2 and TNF associated with T cell activation11,12. IL2 and TNF have 
higher persistent expression in stimulated memory than naïve CD4+ cells2. We used FAIRE-PCR to examine the 
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Figure 5. The role of ETS-1 in transcriptional memory. (a) Flow cytometric analysis of ETS-1 expression 
in peripheral blood lymphocytes, naïve (blue, CD45RO−), and memory (filled red, CD45RO+) CD4+ T cells. 
Cells were left non-stimulated (NS) or stimulated with PMA and calcium ionophore (ST). Dashed lines show 
isotype control staining. Cells were CD3+CD8−. A representative of 4 individuals (biological replicates) is 
shown. (b) ETS-1 binding in the memory regulatory regions (SW > NS, sets d-g) in CD4+ T cells (GSE43119). 
Sequencing tags were binned by 100 bp and shown ± 5 kb from the centre of the FAIRE region. (c) Immunoblot 
of ETS-1 protein levels in nuclear extracts of NS, ST, SW, and RS cells. ETS-1 intensities were normalised against 
Novex (protein loading control). A representative of 3 independent biological experiments is shown. (d) ETS-1 
binding at the BIRC3 promoter and TNFSF10 enhancer in the Jurkat model. ChIP enrichment ratio relative to 
NS. SW cells were rested for 6 days. A representative (mean+ /− SEM with n = 3 PCR (technical) repeats) of 
3 independent biological experiments is shown. (e) ETS-1 protein levels and Novex (protein loading control) 
in Jurkat cells with mock or ETS1 siRNA. (f) Expression of putative ETS targets in mock or ETS-1 siRNA-
treated Jurkat cells. SW cells were rested for 3 days. mRNA levels were measured by RT-PCR and normalised 
to GAPDH. Fold change relative to mock NS is shown. A representative (mean+ /− SEM with n = 3 PCR 
(technical) repeats) of 5 independent biological experiments is shown. (g) Chromatin accessibility (CA) of the 
BIRC3, MIR21, and TNF promoters and TNFSF10 and DUSP10 enhancers in mock or ETS-1 siRNA-treated 
Jurkat T cells. SW cells were rested for 3 days. Chromatin accessibility was measured by FAIRE-qPCR and 
normalised to the GAPDH promoter. Fold change relative to mock NS. A representative (mean+ /− SEM with 
n = 3 PCR (technical) repeats) of 3 independent biological experiments is shown. (d,f,g) *p < 0.05, t-test.
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Figure 6. Altering the initial activation signal selectively affects transcriptional memory. (a) Transcription 
of IL2 and TNF and chromatin accessibility (CA) of their promoters in the Jurkat TM model with different 
initial stimuli. Expression levels were measured by RT-PCR and normalised to GAPDH. Chromatin accessibility 
was measured by qPCR and normalised to the GAPDH promoter. IL2 expression values are mean ± SEM, n = 3 
biological replicates. For TNF expression, values are the average of the RT-PCR (technical) replicates, and error 
bars indicate min-max. Accessibility: mean ± SEM, n = 3 biological replicates. *p < 0.05 compared to NS, t-test. 
(b) The regions with altered chromatin accessibility in ST, SW, or RS compared to NS and whether their increase 
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role of PMA- and I-driven signals in increasing chromatin accessibility at the IL2 and TNF promoters in ST and 
RS cells (Fig. 6a, Fig. S7A).
IL2 and TNF expression was higher in RS cells (Fig. 6a), and chromatin accessibility induced in RS was greater 
than in ST (Fig. 6a). PMA alone increased chromatin accessibility upon initial stimulation (Fig. 6a) and was suf-
ficient to prime cells for enhanced expression in RS even in the absence of increased initial expression (Fig. 6a).
To further dissect the roles of different T cell signalling pathways in regulating chromatin accessibility, 
FAIRE-seq was performed on cells pre-treated with the PKC inhibitor rottlerin before 1° stimulation and washed 
away before 2° stimulation (Fig. S7B). Rottlerin inhibited both an increase and decrease in chromatin accessi-
bility at selected genomic regions in ST, SW, and RS (Fig. S7C,D). In particular, rottlerin treatment influenced 
a greater proportion of chromatin accessibility increases in RS than ST, with the majority of rottlerin-sensitive 
regions being from two transcriptional memory sets: 2°-specific set c and stimulation-dependent set b2 (Fig. 6b). 
Furthermore, those regions with rottlerin-sensitive chromatin accessibility increases in ST had significantly 
higher chromatin accessibility in RS than ST compared to all ST > NS regions (p < 2 × 10−16, Fig. 6c), suggesting 
that the rottlerin sensitive pathways were the same as those enhanced upon RS.
We next used an enrichment approach to identify which transcription factor pathways were affected by rot-
tlerin. When the RS > NS regions were ranked by their chromatin accessibility with and without rottlerin, the 
NFAT, NFκ B, and TCF7L2 motifs were significantly enriched in the regions with higher chromatin accessibility 
in the absence of rottlerin (p ≤ 0.002, Fig. 6d, Table S1). Interestingly we found that chromatin accessibility at 
AP1-containing regions was less rottlerin sensitive (Fig. 6d).
Several memory-responsive genes were within 50 kb of a rottlerin-sensitive RS > NS region (Fig. S8). The 
enhanced 2° expression of three of these memory-responsive genes - TNF, IL8, and ICOS - was also rottlerin sen-
sitive (Fig. 6e), and we confirmed the rottlerin sensitivity of the chromatin accessibility of the regions using qPCR 
(Fig. 6f). All three regions contained an NFAT motif (Fig. S8).
We have previously reported7 that nuclear NFκ B family member RelA protein levels are higher in 
2°-stimulated Jurkat cells, and this was confirmed by immunohistochemistry (Fig. 7a). Furthermore, nuclear 
NFATC1 levels were also significantly higher in RS cells (Fig. 7a). Nuclear NFATC1 did not increase in RS Hut-78 
cells (Fig. 7b), which lack transcriptional memory (unpublished observation). We found that the PKC inhibitor 
C2737 abrogated the enhanced protein levels of NFAT in the nucleus on RS (Fig. 7c).
Taken together, perturbation of the 1° signal in our model using the inhibitor rottlerin revealed two inter-
esting findings. Firstly, that there is overlap in the signalling affected by rotterlin, primarily NFAT and NFκ B 
activation, and the signalling enhanced upon RS. Secondly, that the signalling occurring in the initial activation 
had consequences for the subsequent enhancement of chromatin accessibility and transcription increases upon 
2° stimulation.
The enhanced 2° response of NFAT is ETS dependent. Microarray data suggested that enhanced 
nuclear NFATC1 protein expression in RS cells was due to increased NFATC1 gene expression (Fig. S4A). 
Chromatin accessibility at the NFATC1 promoter was not maintained in SW cells, but several small chromatin 
accessibility peaks were present in SW FAIRE-seq upstream of the TSS, with at least one in an area with enhancer 
chromatin marks in primary CD4+ lymphocytes (Fig. S9A). We confirmed increased chromatin accessibility in 
SW cells of a region with enhancer chromatin marks by qPCR and found that rottlerin pre-treatment significantly 
abrogated chromatin accessibility (Fig. 8a). Given that ETS-1 was strongly associated with chromatin accessibility 
in SW cells, we investigated its role in maintaining chromatin accessibility at this enhancer region. As hypothe-
sised, ETS-1 bound to this region (Fig. 8b), and ETS1 knockdown abrogated the chromatin accessibility on serum 
withdrawal (Fig. 8c). Future experiments would allow confirmation its interaction with the NFATC1 promoter. 
ETS1 knockdown also partially inhibited the enhanced NFATC1 mRNA (Fig. 8d) and nuclear protein levels 
(Fig. 8e) on RS. Interestingly, ETS-1 knockdown decreased the level of NFATC1 protein in the cytoplasm and 
nucleus (Fig. S9B, Fig. 8e) for all treatments, while its effect on mRNA was limited to RS (Fig. 8d).
In addition to regulating NFATC1 expression, the ETS binding motif co-existed with the NFATC1 motif in 
many increased chromatin accessibility regions in RS cells (Fig. 4e). Memory-responsive genes with rottlerin - 
sensitive RS regions and NFAT motifs play important roles in the immune response and include transcription 
factors, cytokines, receptors, and signalling molecules (Fig. 8f). Interestingly, many of these regions also 
contained an ETS motif, with many containing an overlapping NFAT-ETS motif (Fig. 8f). Thus, ETS together 
with PKC pathway-induced factors may promote NFAT activity in several different ways that together play a 
major role in the enhanced chromatin accessibility and transcriptional 2° response of pre-activated T cells.
or decrease was rottlerin sensitive (ROTT sens). The regions are coloured by their chromatin accessibility set. 
(c) The chromatin accessibility ratio in RS/ST of all regions with increased accessibility in ST > NS compared 
to those also SW > NS and those rottlerin sensitive in ST. *p < 0.05 compared to all ST > NS, Wilcoxon test. 
Chromatin accessibility from FAIRE-seq. (d) Regions with increased Chromatin accessibility (RS > NS) were 
analysed for the occurrence of DNA motifs. Regions were ranked according to the ratio of their chromatin 
accessibility in rottlerin-treated RS cells (compared to DMSO RS), the occurrence of the selected motif is 
illustrated by black lines and the enrichment score is plotted against the rank of the regions. (e–f) The effect 
of rottlerin (ROTT) pre-treatment on mRNA expression (e) and chromatin accessibility (f) of the regulatory 
regions near the gene. Expression levels were measured by RT-PCR and normalised to GAPDH. Chromatin 
accessibility was measured by qPCR and normalised to the GAPDH promoter. *p < 0.05, **p < 0.01, t-test, n = 3 
biological repeats, mean ± SEM.
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Discussion
Various immune cells maintain memory of previous activation and produce different transcriptional responses 
upon 2° activation than occur upon 1° activation34,38. There is growing evidence that this transcriptional memory 
is encoded in the epigenome18,34,38,39. Here we used a human T cell culture model with stimuli acting downstream 
of cell surface signalling to explore if the chromatin accessibility landscape “remembers” previous activation and 
to identify the transcription factors required to establish and enhance the chromatin accessibility changes asso-
ciated with rapid gene expression upon re-stimulation. In doing so, we highlight the likely combinatory action of 
transcription factors in regulating inducible genes with memory.
We found that the transcription of many memory-responsive genes corresponded to regions with increased 
chromatin accessibility in RS, which were often located away from the transcriptional start site in cell type-specific 
enhancer regions. Studies using a TNF enhancer region have shown it to interact more strongly with the TNF 
promoter in PMA/I-stimulated T cells27. However, examination of three interactions in our model revealed that 
these enhancer regions were already in close proximity to transcriptional start sites in naïve T cells. Several other 
Figure 7. Cellular localisation and levels of NFATC1 in transcriptional memory and its dependence on 
PKC. (a) The nuclear levels of RelA and NFATC1 in P/I stimulated (ST) and re-stimulated (RS) Jurkat cells.  
(b) The nuclear levels of NFATC1 in P/I stimulated (ST) and re-stimulated (RS) Hut-78 cells. (c) The nuclear 
levels of NFATC1 in Jurkat cells pre-treated with DMSO or the PKC-θ -specific kinase inhibitor C27. (a–c) 
Cells were rested for 1 day after the initial stimulation. DAPI co-staining was used. Representative cells for 
each treatment (10 μ m scale bar) are shown, with total nuclear fluorescence intensity (TNFI) from 3 biological 
replicates with n = 20 cells each, mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001. Mann–Whitney test.
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Figure 8. The role of PKC and ETS-1 in regulating NFATC1. (a) The effect of rottlerin (ROTT) in the Jurkat 
transcriptional memory model on DNA accessibility at an NFATC1 enhancer region. Mean+ /− SEM with 
n = 3 biological repeats. * p < 0.05, **p < 0.01, ***p < 0.001. t-test. (b) ETS-1 binding at the NFATC1 enhancer 
region in the Jurkat memory model. Error bars show min-max of 2 PCR values, with the result representative of 
3 biological repeats. (c,d) The effect of ETS1 siRNA knockdown in the Jurkat transcriptional memory model on 
accessibility at an NFATC1 enhancer region (c) and NFATC1 mRNA expression (d). Representatives (mean+ 
/− SEM with n = 3 PCR (technical) repeats) of 3 independent biological experiments are shown. (e) The 
nuclear levels of NFATC1 in P/I stimulated (ST), SW, and re-stimulated (RS) Jurkat cells pre-treated with mock 
or ETS1 siRNA. SW cells were rested for 3 days. Representative cells are shown (10 μ m scale bar), with total 
nuclear fluorescence intensity (TNFI) from 3 biological replicates with n = 20 cells each mean ± SEM. *p < 0.05, 
**p < 0.01, ****p < 0.0001. Mann–Whitney test. (f) The memory responsive genes within 50 kb of a region with 
rottlerin sensitive increased accessibility in RS and that contained a NFAT motif. Regions that also contained 
ETS-1 motifs are indicated with green lines.
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studies have found evidence for promoter-enhancer interactions in the absence of gene expression30,40,41, sug-
gesting the existence of pre-established (“permissive”) and de novo (“instructive”) loops42. Most similar to our 
study, inducible genes such as CCL2 already had enhancer-promoter loops in the absence of the TNF treat-
ment that induces their expression. The three interactions we examined appear to be “permissive loops”, with 
increased accessibility at the enhancers in the SW state a secondary step and RS-dependent factors a tertiary step 
to enhanced expression. Although beyond the scope of the current study, It would be informative to examine 
additional enhancers and to utilise other methods such as ChiA-PET to investigate interactions in the JTM.
In examining all the different chromatin accessibility change profiles in our JTM model, we identified four 
groups with greater chromatin accessibility in RS than ST: (i) stimulation-dependent (set b2); (ii) persistent tran-
scriptional memory (set e2); (iii) delayed and maintained response (set f); and (iv) 2°-specific (set c). We pro-
pose that all four groups contribute to memory-responsive gene induction and, in agreement with others38, that 
different regions act together to modulate transcription. For instance, NFATC1, FASLG, TNFSF10, and DUSP10 
had multiple nearby chromatin accessibility regions. It is increasingly apparent that not only do multiple regions 
regulate transcription of a target gene, but that chromatin accessibility at each of these regions is regulated by a 
combination of transcription factors that contribute differently at various activation stages.
The stimulation-dependent (set b2) group contained motifs for transcription factor families such as NFAT, 
NFκ B, NR4A, and AP1. For this set, the most likely cause of increased chromatin accessibility in RS cells is 
increased activation of these transcription factors (Fig. 9). While chromatin accessibility at these regions 
increased in RS compared to ST cells, the increases were not maintained in SW cells when nuclear levels of these 
transcription factors decreased. It is possible that, as in macrophages, H3K4me1 is maintained at these regions34 
and some of these regions change chromatin state in memory CD4+ lymphocytes.
The persistent (set e2) and delayed (set f) group were enriched for the ETS motif. ETS-1 is constitutively 
expressed in Jurkat cells, and our results suggest it may play a role in chromatin accessibility in NS in regulatory 
regions that lose chromatin accessibility upon stimulation (such as set h). Similar to the role of the ETS family 
member PU.1 in macrophages34, some regions appeared to require other transcription factors to modify the 
chromatin at regions before ETS-1 can bind. Our work and that of ref. 38 suggest that, in lymphocyte activation, 
members of the AP1, NFAT, EGR, and NFκ B families execute this role. AP1 has previously been shown to tether 
ETS-1 to genes such as TIMP143. However, once ETS-1 binds DNA, it appears to be able to maintain chromatin’s 
open state.
Consistent with its role in memory lymphocyte enhancer regions36 and in agreement with the murine lym-
phocyte study of ref. 38, ETS-1 binding was increased in pre-activated resting lymphocytes, suggesting a role 
Figure 9. Schematic of how transcription factors act in combination to regulate chromatin accessibility 
(CA) in transcriptional memory. In non-stimulated (NS) cells, members of the bHLH, ETS, and TCF7L2 
families maintain chromatin accessibility regions. On stimulation (ST), PKC and calcium signalling pathways 
activate the AP1, EGR, NFκ B, NFAT, and NR4A families, which increase accessibility and de-activate some 
signalling by bHLH members. When stimulus is withdrawn (SW), activation of the induced transcription 
factors ceases but GATA family members gradually build up and, with ETS family members, maintain a subset 
of the chromatin accessibility regions and make additional regions accessible. These regions include a potential 
NFATC1 enhancer. On re-stimulation (RS), there is re-activation of the induced transcription factors with 
increased activation of NFκ B, NFAT, and NR4A, leading to increased chromatin accessibility at some regions 
that had increases before and secondary-specific chromatin accessibility at additional regions. The factor ZEB 
is also activated more upon RS and inhibits accessibility, while differential expression of ID proteins and bHLH 
members lead to decreases in chromatin accessibility in SW and RS. Weakening of the initial PKC signal by 
rottlerin (ROTT) partially inhibits chromatin accessibility induced by NFκ B and NFAT in the primary and 
subsequent stimulation. Increased chromatin accessibility marked by x. Purple line represents NR4A genes, blue 
line is NFATC1 gene.
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for ETS-1 in maintaining chromatin accessibility (Fig. 9). A recent study44 on chromatin accessibility in Tregs 
showed that ETS bound sites were accessible before Foxp3 was present and that ETS might keep these sites open 
for Foxp3. At the NFATC1 enhancer, ETS1 knockdown partially inhibited chromatin accessibility at regions such 
as the BIRC3 promoter, but, surprisingly, had more of an effect on increasing chromatin accessibility in RS than 
SW cells. This could be due to incomplete knockdown or redundancy with other ETS family members such as 
ELF-1 or ETV5, or it could suggest a more complex role for ETS in regulating increased chromatin accessibility in 
RS. ETS-1 and other ETS family members are known to recruit histone acetylases45,46, and the presence of ETS-1 
may affect histone acetylation in SW cells and play a role in recruiting factors that control enhanced chromatin 
accessibility in RS or recruiting other transcription factors.
ETS motifs also marked the 2°-specific set (c). However, the NFAT motif appeared to be most critical for 
determining these regions, and several known NFAT targets including CSF2, EGR2, NR4A2, IL8, FASLG, and 
TNF are near these regions15,47–49. Alone, NFAT members only weakly bind DNA, and its regulation of transcrip-
tion co-depends on AP1, GATA, and EGR members48,50, a phenomenon highlighted by our examination of motif 
co-occurrence in set c with NFκ B, NR4A, GATA, and EGR motifs also being enriched. Different transcription 
factor combinations may also continue to affect the immunological outcome, such that NFAT-AP1 co-binding 
induces immune response genes, while NFAT binding without AP1 induces anergy-associated genes47.
The activities of several members of the NFAT family (except for NFAT5) are regulated by calcium signalling48. 
NFAT5 and NFATC1 show inducible expression51, with NFATC1 induced more in CD4+ memory cells than naïve 
cells7,38,52. NFATC1 and NFAT5 were both induced in Jurkats, with NFATC1 induced more in RS. NFATC1 induc-
tion is under the control of two alternative promoters and at least one intronic enhancer53. While auto-regulation 
plays a large role in the induction of NFATC1, NFκ B has also been shown to bind to and regulate one of the pro-
moters (P1)51,53. Increased NFAT activation upon RS may be partly due to higher NFκ B activity acting through 
P1. There was more nuclear RelA protein accumulation and higher expression of REL and NFKB1 in RS in the 
JTM, consistent with greater NFκ B activity on activation in primary memory than naïve cells54. However, it is 
likely that there is more than one cause of enhanced NFATC1 induction in memory T cells. We also identified 
a region upstream of NFATC1 that became accessible in SW cells and has enhancer chromatin marks in CD4 
lymphocytes; we propose that this could act as an NFATC1 enhancer, although further experiments would allow 
confirmation of its interaction with the NFATC1 promoter. This region was bound by ETS-1 in SW cells and may 
be responsible for the ETS-1-dependent NFATC1 induction. While the decreased nuclear levels of NFATC1 in RS 
cells on ETS1 knockdown could be attributable to decreased transcript, the inhibitory effect in ST cells appeared 
to be independent of mRNA levels. This may implicate ETS-1 and/or its targets in the control of NFAT protein 
stability.
In addition to regulating NFATC1 mRNA, ETS-1 and NFAT physically interact in T cell nuclei, and NFAT 
recruitment to the IL2 promoter decreases in the absence of ETS55. There is partial ETS and NFAT binding motif 
overlap (Fig. 8f), resulting in many NFAT targets containing composite sites. Hence, increased ETS-1 in SW may 
help to recruit NFAT more quickly to the enhancers of memory-responsive genes.
NFAT is implicated in regulating chromatin accessibility via recruitment of remodellers BRG and BRM56 and 
histone modifiers such as p30057. Acetylases such as p300 are thought to maintain transcriptional memory39. We 
found that increased chromatin accessibility was associated with the development/widening of an NFR, increased 
relative H3.3 levels, and, in some cases, relative histone acetylation. Interestingly, these changes were inherited 
through cell divisions. This is unlikely to be due to DNA methylation due to the low CG content of the regions 
(results not shown) but is thought to be linked to BRD4 binding38.
Our motif co-occurrence analysis showed that an important determinant of enhanced chromatin acces-
sibility upon re-stimulation was the absence of a bHLH or ZEB motif. The repressors ZEB2 and ID2 are 
memory-responsive genes in the JTM model and ZEB2 is an NFAT target47. There was further decreased chro-
matin accessibility of regions with the ZEB binding motif in RS or increased chromatin accessibility only in ST 
(Fig. 9). Thus, NFAT may also indirectly regulate the further decrease in chromatin accessibility in RS.
In addition to being dependent on ETS-1, NFATC1 enhancer chromatin accessibility was dependent on PKC 
signalling in ST. Partial abrogation of the initial PKC signal by rottlerin not only affected chromatin accessi-
bility in ST but continued to affect chromatin accessibility in SW and RS. The regions most sensitive to rot-
tlerin in RS were marked by NFAT and NFκ B motifs, while fewer of those with AP1 motifs were affected. We 
found that NFAT nuclear accumulation was dependent on PKC-θ signalling using the C27 inhibitor. NFκ B 
inhibition by rottlerin was expected, as NFκ B is a known PKC signalling target13. We previously7 found that 
stimulation-dependent NFATC1 expression in CD4+ naïve and memory T cells is PKC-θ dependent by siRNA 
knockdown. Furthermore, the PKC-θ inhibitor AEB071 inhibits NFκ B and NFAT but not AP1 activity58. The 
results with rottlerin suggest that naïve cells exposed to different initial stimuli may be primed differently for gene 
expression upon re-stimulation. Differential TCR signalling strength and quality affect not only the development 
of the memory phenotype, but also TCM/TEM balance14,59. It would be informative to study the epigenomes of 
lymphocytes with differing activation signals to determine if they are poised differently. Indeed, it was interesting 
that we observed differences in the relative accessibility in memory and naïve lymphocytes between individuals. 
The extent of these differences and how they relate to the individual’s ability to induce the corresponding genes 
remains to be determined. Differences in the CD4+ lymphocyte epigenomes of individuals have been found to 
relate to factors such as disease status and age60–62 and factors such as TCM/TEM balance may also play a role.
In conclusion, we show that T cell activation irreversibly changes the chromatin landscape and affects subse-
quent gene expression profiles if the cells are re-stimulated. NFATC1 and ETS play important roles in enhanced 
2° responses, and the strength of initial PKC signalling affects chromatin accessibility changes via NFAT and 
NFKB motifs.
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Methods
Jurkat T cell culture. Human Jurkat T cells (Clone E6-1, ATCC TIB-152) were pre-treated with either 
DMSO, 15 μ M rottlerin (Calbiochem, Merck Millipore, Billerica, MA), or 1 μ M C27 (SYNthesis med chem, 
Parkville, Victoria) for 1 h (rottlerin) or 2 h (C27) followed by stimulation with 24 ng/mL phorbol 12-myristate 
13-acetate (PMA; Sigma-Aldrich, St. Louis, MI) and/or 1 μ M calcium ionophore (I; Sigma-Aldrich) for 2h at a 
density of 5 × 105 /mL. Primary activated Jurkat T cells were washed three times with stimulus-free medium and 
re-cultured for up to six days prior to PMA/I re-stimulation as previously described7. Jurkat and HUT-78 cells 
were cultured in RPMI 1640 supplemented with 10% FBS and 4 mM L-glutamine.
Human T cell isolation. Human blood was obtained from healthy volunteers recruited after obtaining 
informed written consent in accordance with QIMR Berghofer Medical Research Institute Human Research 
Ethics Guidelines and approved by the QIMR ethics committee, ethics approval number P158. Peripheral blood 
mononuclear cells (PBMCs) were isolated from heparinised blood by Ficoll-Paque PLUS (GE Healthcare, Little 
Chalfont, UK) density centrifugation and labelled with CD8α -PerCP, CD4-PE Cy7, CD3-APC, CCR7-Alexa 
Fluor700, and CD45RA-FITC (BD Biosciences, San Jose, CA) antibodies and subsequently sorted for CD4+ naïve 
(CD45RA+ CCR7+ CD27+) and memory (CD45RA−) cells using the FACS Aria (BD Biosciences) cell sorter.
Flow cytometry. For carboxyfluorescein succinimidyl ester (CFSE) analysis, previously stimulated (2 h) 
Jurkat cells were incubated with CFSE (10 μ M) in PBS (with FCS 5%) for 10 min before being washed and 
re-cultured in RPMI. Fluorescence was measured using the LSRII flow cytometer (BD Biosciences) and analysed 
with FlowJo. The background fluorescence of unstained cells was subtracted from each intensity measurement, 
and the values were compared to day 0 cells. One cell division was presumed to be equal to a 2-fold intensity 
decrease.
For Ets-1 intracellular staining, PBMCs from healthy volunteers were stained with CD3 AF700, CD4 BV605, 
and CD45RO Texas Red monoclonal antibodies (BD Biosciences) then permeabilised and fixed using the FoxP3 
permeabilisation solution kit (BioLegend, San Diego, CA). The fixed cells were then stained with the Ets-1 anti-
body directly conjugated to Alexa 647: IgG1 monoclonal antibody, 8A8 clone, (1/100, Thermo Fisher Scientific, 
Waltham, MA) or isotype control IgG1 (Thermo Fisher Scientific).
Ets-1 siRNA transfection. Jurkat T cells were transfected with Ets-1 siRNAs (Santa Cruz Biotechnology, 
Dallas, TX) using the NeonTM Transfection System Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
instructions. Control siRNA-A (Santa Cruz Biotechnology) was used as negative control. Briefly, Jurkat T cells 
were re-suspended in Neon Re-suspension Buffer R at a concentration of 2 × 107 /mL, and each construct was 
transfected at a final concentration of 200 nM per 1 × 106 Jurkat T cells in a 100 μ l transfection volume using the 
Neon electroporation transfection system. Cells were cultured in 2 mL of antibiotic-free medium at a density of 
5 × 105 /ml in 6-well plates for 2 days followed by PMA/I stimulation. Cells were rested for three days after stim-
ulus withdrawal and re-stimulated.
Western blotting. Western blot analysis of Jurkat cell nuclear extracts was performed using a primary 
anti-rabbit antibody to Ets-1 (SC-350) and a secondary HRP-conjugated anti-rabbit antibody (AP187P; Merck 
Millipore). Signals were detected by enhanced chemiluminescence with film exposure. The intensity of bands 
of the correct molecular weight were analysed with ImageJ, and protein loading was normalised with a highly 
sensitive quantitative total protein loading control detection kit (Novex Reversible Membrane Protein Stain Kit, 
Novex, Invitrogen).
Immunofluorescence microscopy. Cells were permeabilised by incubation with 2% Triton X-100 for 
20 min. Cells were probed with primary antibodies to either NFATC1 or Rela followed by visualisation with sec-
ondary rabbit (A10042; Life Technologies), mouse (A31574; Life Technologies), goat (A11055; Life Technologies) 
immunoglobulins conjugated to Alexa Fluor 488, 568, or 633 nm and co-stained with DAPI. Staining was ana-
lysed by confocal laser scanning microscopy. Single 0.5 μ m image stacks were obtained using a Nikon x 60 oil 
immersion lens on the Nikon C1 plus confocal system and the final image obtained by averaging four sequential 
images from the same tissue section. Digital confocal images were analysed with Fiji-ImageJ software63 to deter-
mine the total nuclear fluorescence intensity (TNFI) by selecting a region of interest (ROI) corresponding to the 
nucleus with background subtracted measured in a minimum of 20 cells for each sample set.
RNA extraction and quantitative reverse transcription PCR (qRT-PCR). Total RNA was extracted 
from Jurkat cells using TRIzol® Reagent (Invitrogen) followed by chloroform extraction (Sigma) and isopro-
panol (Thermo Fisher Scientific) precipitation. First-strand cDNA was synthesised from 1 μ g total RNA using 
the SuperScriptTM III First-Strand Synthesis System (Invitrogen). qRT-PCR was carried out to determine gene 
expression with gene-specific TaqMan probes in the Applied Biosystems® ViiATM 7 Real-Time PCR System (Life 
Technologies). The sequences of all primers used in this study are listed in Table S2 in the supplemental material.
Chromosome conformation capture (3C) assay. The 3C assay was performed according to ref. 31, 
except that DpnII (Genesearch, Arundel, Australia) was used as the restriction enzyme. DNA was quantified by 
SYBR real-time PCR with the primer sets listed in Table S2. 3C-qPCR data were normalised to a GAPDH loading 
control and primer efficiency was normalised to bacterial artificial chromosome (BAC) clones including gene 
deserts (GD), DUSP10, TNFSF10, and BCL6 (Life Technologies).
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Chromatin immunoprecipitation (ChIP). ChIP-PCR was performed with Magna ChIPTM Protein 
A Magnetic Beads (Merck Millipore) as described previously64. ChIP-DNA enrichment was performed with 
antibodies targeting H2AZ, H2AZAc, H3, H3.3, H3K27ac, H3K56ac, and Ets1. ChIP-DNA was quantified by 
real-time PCR with the primer sets listed in Table S2 in the supplemental material.
Formaldehyde-assisted isolation of regulatory elements (FAIRE). FAIRE samples were prepared as 
outlined in ref. 65. Briefly, cells were cross-linked with 1% formaldehyde and lysed. The cell lysates were sonicated 
to yield an average DNA fragment distribution of approximately 200 to 500 bp. A 50 μ L aliquot of fragmented 
DNA (total input control DNA) was reverse cross-linked at 65 °C followed by phenol-chloroform extraction. The 
remaining sonicated DNA (FAIRE DNA) was directly isolated by phenol-chloroform extraction and purified 
using the Zymo-SpinTM I kit (Zymo Research). 50 ng of FAIRE DNA and the corresponding total input DNA 
were used to prepare the FAIRE-seq DNA library using the NEBNext® Ultra DNA Library Prep Kit for Illumina® 
(New England BioLabs Inc., Ipswich, MA) according to the manufacturer’s instructions. FAIRE DNA libraries 
were single-end 50 bp sequenced on an Illumina HiSeq2000 at the Ramaciotti Centre for Genomics, University 
of New South Wales, Sydney.
Bioinformatics analysis. FAIRE sequencing reads were stripped of adapter sequences with CutAdapt66, 
mapped to the human (Hg19) genome with global alignment in Bowtie267, and duplicate reads were removed 
with Picard (http://picard.sourceforge.net). Areas of enrichment in the DMSO FAIRE samples compared to the 
total input sample were determined using MACS268 with the Broad option and using a q-value cut-off of ≤ 0.05. 
Regions from the four DMSO samples were pooled (in Galaxy) with overlapping regions merged into one. In 
total, 40,731 regions were detected (28 were removed because they were on chrM or chrUn). Reads were extended 
to 200 bp and the number of sequencing reads in each region for all samples (DMSO and rottlerin treated) were 
counted in R. The counts were MA normalised to each other in R. Using the NS DMSO and rottlerin treated 
comparison as a guide, a 1.75-fold change with a minimum read number of 30 was used as a cut-off for calling 
regions with changed CA. Based on the NS comparison, this was expected to give 242 regions as false positives or 
a 8.5–14.5% false positive rate.
The mid-points of the regions were annotated to the nearest ENSEMBL transcript using the ChIPpeakAnno 
package in R. As a region can be annotated to more than one transcript, regions were allocated to groups in 
the following order: 5′ UTR, 3′ UTR, exon, intron, promoter, upstream, and intergenic. A promoter was defined 
as the area − 1 kb to 0 bp from the TSS and upstream was defined as − 10 kb to − 1 kb from the TSS. Regions 
were also annotated to RoadMap CD4+ memory chromatin state data22 and ChIP-seq data from naïve, memory, 
and PMA/I activated Th CD4+ cells donor 62 (GSE17312). Homer69 was used to profile the RoadMap histone 
marks + /− 1 kb (0.1 kb bins) around the FAIRE peaks, and values were scaled by total mapped reads. Wilcoxon 
tests were performed with continuity correction in R. DAVID70 was used to look for over-represented Gene 
Ontology groups in the genes nearest to the accessible regions. ST > NS, SW > NS, and RS > NS regions were 
compared to the NS region background. A p value < 0.05 and FDR < 25% cut-off were used to determine signifi-
cance, and groups had to have at least 10 genes present. Homer69 and CLOVER (with JASPAR PWM database)71 
were used to identify over-represented transcription factor binding motifs. For both programs, the regions were 
standardised to 300 bp (or 500 bp for co-occupancy) and while HOMER uses genomic regions with similar GC 
content as background, for CLOVER NS regions were used as background. Motifs had to have a q (HOMER) or p 
(CLOVER) value of ≤ 0.05. GSEA72 was used to investigate the motif occurrence significance in regions differen-
tially affected by rottlerin treatment, with sets of regions (set to 300 bp) containing JASPAR motifs (at least 2 motif 
occurrences, from CLOVER) instead of the usual gene lists. Regions were ranked using fold-changes, and region 
(‘gene’) permutation was used to establish significance. Motif co-occupancy was analysed in R using output from 
the CLOVER program and custom scripts (available on request). To explore the combinatory effect of different 
factors on chromatin accessibility outcomes, we examined every pairwise combination of the 14 enriched motifs 
in all regions with altered chromatin accessibility (a–n). We determined how many of the regions with both 
motifs belonged to a particular set as a percentage of all the sets (a-n) with altered chromatin accessibility. We 
also compared the composition of regions with 1 motif but not the other. Furthermore, based on the pairwise 
combinations, we examined several 3 motif combinations.
Genes were classified as primary response genes or memory-responsive genes if they had at least log2 0.5 
greater expression in ST (day 0, primary response genes) or RS cells (day 9, memory-responsive genes) compared 
to NS and either RS (primary response genes) or ST cells (memory-responsive genes). Expression for Jurkat cells 
from GSE611727 and primary cells from E-MEXP-2578.
FAIRE data was deposited in GEO under accession number GSE63766.
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